CD24 and triple-negative breast carcinoma: Previous studies have shown that CD44+/CD24- breast CSCs may be a dominant factor for the relapse of triple negative breast cancer (TNBC), due to their potent self-renewal and differentiation capacities (Geng et al., 2014; Wang et al., 2014).